Kelly M. Rangel

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer”.

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer

Cell Reports(2020)10.1016/j.celrep.2020.03.066

N/A

0DataRank · unranked

143 citations

Li Zhao, Christine Rojas, Nicholas W. Bateman, Hui Yao, Olivia D. Lara +41 more

Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100003

N/A

0DataRank · unranked

49 citations

Stacey Cranert, Kelly M. Rangel, Ayad Ali, Ivayla E. Gyurova, Arthur T. de la Cruz-Lynch +7 more

Correlation of HRD status with clinical and survival outcomes in patients with advanced-stage ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5568

N/A

0DataRank · unranked

5 citations

Anil K. Sood, Shannon N. Westin, Bryan Fellman, Jenna Unke, Kelly M. Rangel +3 more

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer

Cancers(2022)10.3390/cancers14061496

N/A

0DataRank · unranked

23 citations

Nicholas W. Bateman, Sanghoon Lee, Li Zhao, Jun Yao, Yukun Tan +14 more

Feasibility of using the handheld MasSpec pen technology for intraoperative identification of ovarian cancer during tumor reductive surgery.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.5573

N/A

0DataRank · unranked

1 citations

Charles A. Wolfe, Michael F. Keating, Marta Sans, Kelly M. Rangel, Calvin Sunny +10 more